Principle Criteria
Free Enterprise
Property Rights
Personal Responsibility
Limited Government
Individual Liberty
Digest
SB 2336 expands the Texas Pharmaceutical Initiative by increasing the governing board size from three to five members and adjusting their terms and vacancy procedures. It mandates the board to submit a business plan every two years outlining the initiative’s structure, policies, cost savings, and recommendations for manufacturing generic drugs, gene therapies, and precision medicine. The bill also establishes new compliance procedures for conflict-of-interest laws and state agency participation in the initiative.
Author
Lois Kolkhorst
Contact the Author
Sen. Lois Kolkhorst
Capitol Phone:
(512) 463-0118
Capitol Office:
CAP GE.4
E-Mail:
